Influence of a written or oral patient information program in daily clinical practice on adherence and persistence with an aromatase inhibitor in adjuvant primary breast cancer treatment in comparison to standart clinical care within outcome research.
Not Applicable
- Conditions
- breast cancerComplianceC50Malignant neoplasm of breast
- Registration Number
- DRKS00004826
- Lead Sponsor
- KGM, Phillips-Universität Marburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 181
Inclusion Criteria
•Female
•Primary breast cancer
•Aromatase inhibitor therapy following German breast cancer guidelines [30]
•Informed consent
•Patient is capable of using oral medication on her own initiative following prescribing information
Exclusion Criteria
•Continuously hospitalized, staying in nursery home or receive support via an ambulatory home care service or similar
•Suffer from any form of dementia or similar disease with interference of memory
•Other disease or mental or physical disorder that, in the opinion of the study coordinator, would interfere with participation in the study
•Known medical, drug or alcohol abuse.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method proportion of patients classified adherent” after 12 months; patients were classified adherent if both self-report and prescription refill revealed an adherence above 80%
- Secondary Outcome Measures
Name Time Method Persitence, reasons for non-compliance,possible factors influencing adherence and persistence, reasons for non-adherence and discontinuation, influence of the interventions on other factors as knowledge and quality of life. Data was collected with questionaires combined with interviews at visits 0,12 and 24 months.